Atlas Trials

Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen

Clinical trial NCT02577042 · COMPLETED

Trial details

NCT number
NCT02577042
Sponsor
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Aging-related Inflammation in HIV-infected Patients
Start date
2015-10-15
Primary completion
2018-06-04
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.